RhumbLine Advisers
ENTL

RhumbLine Advisers’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

RhumbLine Advisers’s Portfolio ENTL Stock Details ENTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,713
Closed -$261K – 2838
2017
Q4 		$261K Sell
10,713
-2,060
-16% -$39.6K ﹤0.01% 2525
2017
Q3 		$236K Buy
12,773
+751
+6% +$13K ﹤0.01% 2658
2017
Q2 		$199K Buy
+12,022
New +$167K ﹤0.01% 2762

RhumbLine Advisers's ENTL Position: Q1 2018 in Review

RhumbLine Advisers sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 10,713 shares — an estimated $261K sold.

RhumbLine Advisers first reported a position in ENTL in Q2 2017 and held it in 3 quarters. The position peaked at $261K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

  • RhumbLine Advisers reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • RhumbLine Advisers sold 10,713 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $261K.
  • RhumbLine Advisers first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • RhumbLine Advisers's Entellus Medical, Inc. Common Stock position peaked at $261K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on RhumbLine Advisers's 13F filing for Q1 2018, filed 2 May 2018.